Skip to main content

Table 1 Baseline characteristics of subjects in the Zinc and Placebo groups

From: Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial

CharacteristicsZinc (n = 18)Placebo (n = 22)
Age (years)a35.63 ± 3.232.95 ± 1.7
Sex (n/%)
 Male6 (24%)8 (32%)
 Female19 (76%)17 (68%)
Past experiences with weight-reducing treatment (n/%)
 Yes15 (60%)13 (52%)
 No10 (40%)12 (48%)
Marital status (n/%)
 Single8 (32%)9 (36%)
 Married17 (68%)16 (64%)
  1. aValues are mean ± SD